Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque-Type Psoriasis”

168 trials

Showing 20 of 168 results

Large-scale testing (Phase 3)Study completedNCT00723528
What this trial is testing

An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen Pharmaceutical K.K. 158
Large-scale testing (Phase 3)WithdrawnNCT01900782
What this trial is testing

Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT01309737
What this trial is testing

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 960
Testing effectiveness (Phase 2)Study completedNCT01132612
What this trial is testing

AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 275
Post-approval studies (Phase 4)Study completedNCT01876875
What this trial is testing

N-3 Polysaturated Fatty Acids-rich Diet in Psoriasis

Who this might be right for
Plaque-type PsoriasisObesity (Body Mass Index >30 kg/m2)
Federico II University 44
Large-scale testing (Phase 3)Study completedNCT01690299
What this trial is testing

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Who this might be right for
PsoriasisPsoriatic Arthritis
Amgen 250
Large-scale testing (Phase 3)Study completedNCT01321164
What this trial is testing

Fumaric Acid Versus Fumaric Acid Plus Narrow Band Type B Ultraviolet (UVB) for Psoriasis

Who this might be right for
Plaque Psoriasis
Medical University of Vienna 30
Testing effectiveness (Phase 2)Study completedNCT02173301
What this trial is testing

Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Dr. Reddy's Laboratories Limited 200
Large-scale testing (Phase 3)Study completedNCT03066609
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 543
Post-approval studies (Phase 4)Study completedNCT00852761
What this trial is testing

Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis

Who this might be right for
Plaque-Type Psoriasis
Stiefel, a GSK Company 34
Testing effectiveness (Phase 2)Study completedNCT02622386
What this trial is testing

The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
University of Michigan 23
Testing effectiveness (Phase 2)Study completedNCT00725348
What this trial is testing

An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
Stiefel, a GSK Company 19
Testing effectiveness (Phase 2)Study completedNCT00604682
What this trial is testing

Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
Amgen 19
Large-scale testing (Phase 3)Ended earlyNCT01163253
What this trial is testing

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 2,867
Large-scale testing (Phase 3)WithdrawnNCT01936688
What this trial is testing

Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)

Who this might be right for
Plaque-type Psoriasis
Sun Pharmaceutical Industries Limited
Large-scale testing (Phase 3)Study completedNCT02016105
What this trial is testing

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira

Who this might be right for
Plaque Type Psoriasis
Sandoz 465
Post-approval studies (Phase 4)Study completedNCT03440736
What this trial is testing

Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome

Who this might be right for
PsoriasisMetabolic Syndrome
Novartis Pharmaceuticals 781
Testing effectiveness (Phase 2)Study completedNCT02908347
What this trial is testing

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

Who this might be right for
PsoriasisPlaque Psoriasis
MetrioPharm AG 46
Large-scale testing (Phase 3)Study completedNCT02074982
What this trial is testing

Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Type Psoriasis
Novartis Pharmaceuticals 676
Not applicableStudy completedNCT02107482
What this trial is testing

Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 21
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation